Oxygen concentrator insurance coverage in India: reimbursement, CGHS, ESIC, and private policies

Most Indian families discover the coverage problem only after the prescription is written. The pulmonologist recommends a home oxygen concentrator; the family assumes the health policy that covered the hospitalisation will cover the machine; a week later, the Third Party Administrator sends a one-line rejection: “durable medical equipment is not payable.” The device is not cheap — a 5 LPM concentrator sits between ₹45,000 and ₹85,000 in 2026, a 10 LPM unit between ₹95,000 and ₹1,75,000, and a portable oxygen concentrator (POC) between ₹1,85,000 and ₹3,50,000.

This article maps the actual coverage landscape: what CGHS and ESIC pay for home oxygen and at what rate, what private insurers (Star, HDFC Ergo, ICICI Lombard, Tata AIG, Bajaj Allianz) do and don’t cover, the pre-authorisation workflow, cashless versus reimbursement differences, the documentation that a claim needs, the reasons claims get rejected, and the appeal path when the rejection is wrong. Rent-vs-buy interacts with coverage in non-obvious ways; that is covered at the end.

The default assumption is wrong

Start here: standard indemnity health insurance policies in India are built around hospitalisation. The Insurance Regulatory and Development Authority of India (IRDAI) standard wordings permit Durable Medical Equipment (DME) coverage as an optional inclusion, but do not mandate it. The result is that the overwhelming majority of policies exclude DME by default. The policy wording that matters usually reads along the lines of: “Expenses incurred on purchase or rental of durable medical equipment including oxygen concentrators, CPAP/BiPAP machines, wheelchairs, hospital-type beds, and similar equipment for home use are not payable.” (IRDAI)

A second, easier-to-miss exclusion sits on top: the IRDAI List I of non-payable items, which excludes oxygen masks, nebuliser masks, humidifier bottles, and certain respiratory accessories even during hospitalisation. A patient discharged on home oxygen therefore encounters two coverage gaps — the mask used in ICU (List I), and the concentrator prescribed at discharge (DME). (IRDAI)

The exclusion is economic, not clinical. DME is a long-tail outpatient expense insurers have not priced into standard indemnity wordings. IRDAI mandates introduced over the past decade — AYUSH, mental health — have not extended to DME. Until a mandate arrives, the default is exclusion.

CGHS: the benchmark

The Central Government Health Scheme (CGHS) is the clearest coverage channel in India for home oxygen. It is available to serving and retired central government employees and their dependants across 80+ CGHS cities. CGHS rates are fixed by the Ministry of Health and Family Welfare and published in periodic rate revisions. (CGHS)

For oxygen concentrators, the CGHS route usually works one of two ways: empanelled equipment suppliers directly bill CGHS (cashless for the beneficiary), or the beneficiary pays upfront and claims reimbursement. The reimbursement rate is the CGHS-approved ceiling for the equipment category — not the sticker price the family paid. In practice, CGHS-approved concentrator rates lag the market: a 5 LPM concentrator may reimburse between ₹35,000 and ₹50,000 even when the invoice is ₹65,000. The gap is on the beneficiary.

For rental, CGHS typically reimburses monthly rental for a capped period (often 3–6 months for post-discharge LTOT trials). Beyond that, conversion to purchase is usually required and goes through the empanelled dealer process.

Documentation required:

• Pulmonologist or treating doctor’s prescription, naming the patient, flow rate, and estimated duration
• Arterial blood gas (ABG) report or SpO2 on room air, documenting hypoxemia
• Quotation from an empanelled vendor
• Itemised invoice with GST breakup (post-purchase)
• Warranty card and serial number
• CGHS beneficiary card photocopy

The CGHS Wellness Centre in-charge’s signature is required on the prescription before the claim is filed. This is the most common procedural failure point.

ESIC: narrower but real

The Employees’ State Insurance Corporation (ESIC) covers insured persons (employees earning below a wage ceiling, currently ₹21,000 per month) and their dependants. ESIC has its own empanelled hospitals and equipment channels. Home oxygen coverage under ESIC exists but is tightly scoped — typically provided through ESIC hospital tie-ups and restricted to the specific post-discharge clinical indication. (ESIC)

The practical path is almost always: ESIC hospital discharge with oxygen prescription → ESIC empanelled dealer supplies the unit → ESIC pays the dealer directly. Reimbursement-route claims for units purchased from non-empanelled dealers are generally not entertained. Families of ESIC beneficiaries who buy outside the empanelled channel discover, late, that the claim has no pathway.

PMJAY (Ayushman Bharat)

PMJAY is the national public health insurance scheme for economically weaker sections. It covers hospitalisation under defined packages; home oxygen is not an independent package. Some states have added home oxygen into state-specific PMJAY extensions, but this is not nationally uniform. Families eligible for PMJAY should check with the State Health Agency before assuming coverage for home oxygen.

Private insurers: the narrow door

Star Health, HDFC Ergo, ICICI Lombard, Tata AIG, and Bajaj Allianz dominate the Indian private health insurance market. None of their flagship indemnity products include home oxygen as a standard benefit. What exists instead is a patchwork of optional add-ons, critical illness riders, and a small set of home healthcare products that carry DME coverage:

• Home healthcare / home care add-ons. A handful of products — often marketed as “comprehensive care” or “home hospitalisation” plans — include home medical equipment up to a sub-limit. Sub-limits range from ₹25,000 to ₹1,00,000 and are typically per-policy-year, not per-claim. HDFC Ergo Optima Restore and ICICI Lombard Complete Health variants have carried such riders in specific product years.
• Post-hospitalisation expenses clause. Every indemnity policy covers a window of post-hospitalisation expenses (usually 60 or 90 days). Some insurers have extended interpretation of this clause to rental of a concentrator for the post-discharge recovery window — not purchase. The interpretation is not uniform across insurers, and not guaranteed across policy years of the same insurer.
• Senior citizen products. Star Health’s senior-focused products (Red Carpet, Senior Citizens Red Carpet) have historically included home nursing and some equipment coverage. Sub-limits are tight.
• Corporate group policies. Group mediclaim policies negotiated by large employers sometimes include DME via rider. The employee’s HR team, not the insurer’s customer service, is the right place to verify.

The pattern across all of these: coverage exists where you find the specific rider, is capped, and requires pre-authorisation.

Cashless versus reimbursement

Two claim workflows exist and they are not equivalent for DME.

Cashless requires the equipment vendor to be empanelled with the insurer’s TPA network. In practice, DME empanelment lags hospital empanelment by a wide margin. Most oxygen concentrator dealers in India are not empanelled with any private-insurer TPA. The cashless workflow is therefore unavailable even when the policy covers DME.

Reimbursement requires the beneficiary to pay the dealer upfront, collect the complete documentation set, and submit the claim within the policy’s claim window (usually 30–60 days post-purchase). This is the default path for private DME claims.

CGHS and ESIC have their own cashless channels through empanelled vendors.

Documentation that a claim needs

The claim file that maximises approval probability contains:

1. Prescription, on the treating doctor’s letterhead, naming the patient, diagnosis, specific flow rate (e.g., 2 LPM continuous), duration (e.g., 16 hours/day for 12 months, to be reassessed), and the medical justification (e.g., “PaO2 54 mmHg on room air, consistent with GOLD-grade LTOT criteria”). (GOLD Report)
2. ABG or SpO2 documentation confirming hypoxemia. Insurers increasingly ask for the primary objective measurement, not just the prescription text.
3. Quotation from the vendor, on letterhead, listing the specific make, model, and serial number of the unit being supplied.
4. Itemised invoice with GST breakup post-purchase. GST on medical devices is generally 12%; invoices that miss this line or bundle tax into the base price trigger rejection.
5. Warranty card stamped and signed by the dealer.
6. Proof of payment — UPI reference, cheque image, or bank statement extract.
7. Discharge summary from the most recent hospitalisation, if the oxygen was prescribed at discharge.
8. Policy copy and claim form, filled and signed by the beneficiary.

Missing any one of these extends processing time by 2–4 weeks or triggers an outright rejection.

Typical rejection reasons

Five patterns account for the majority of DME claim rejections:

1. “DME is excluded under the policy.” This is correct in the majority of cases and cannot be appealed on its own — the rejection is based on the policy wording the beneficiary agreed to.
2. “Equipment for home use not payable.” Variant of the above with the same legal standing.
3. “Prescription does not justify the need for durable equipment at home.” This is appealable if the prescription is explicit and the ABG or SpO2 data supports LTOT.
4. “Vendor is not empanelled.” Applies to cashless claims; reimbursement claims do not depend on empanelment unless the policy specifies.
5. “Incomplete documentation.” Missing GST breakup, missing serial number, missing discharge summary. Appealable by providing the missing document.

A sixth pattern, less common but important, is the “pre-existing condition” rejection — the insurer argues that the underlying lung disease pre-dated the policy’s waiting period. This is more often applied to hospitalisation claims than DME claims but does surface.

The appeal path

When a claim is rejected, the first step is to request the rejection letter in writing with the specific policy clause cited. A verbal or email rejection without clause citation is not a final rejection. The IRDAI rules require insurers to state the policy clause basis for every rejection.

With the rejection letter in hand:

1. File an internal appeal with the insurer’s grievance redressal officer. Every insurer is required to publish this officer’s contact details. The appeal must be filed within 30 days of rejection. A well-drafted appeal cites the specific policy clause, provides the missing documentation (if the rejection was for incompleteness), and references the clinical justification.
2. Escalate to the Insurance Ombudsman if the internal appeal is rejected or not responded to within 30 days. The Insurance Ombudsman scheme covers claims up to ₹50 lakh for individual policyholders and is a free, quasi-judicial forum.
3. Consumer forum is the final route. Medical device reimbursement disputes have been heard at District Consumer Commissions with mixed outcomes — the commission looks at the policy wording and the clinical justification jointly.

The Ombudsman route resolves faster than the consumer forum in most cases but is capped at ₹50 lakh claim value, which is not a constraint for concentrator claims but matters for combined claims.

Rent versus buy: the claim-eligibility interaction

A detail that catches families out: rental and purchase do not have the same coverage treatment.

Rental of DME for a short post-hospitalisation window is more likely to be reimbursed under the post-hospitalisation expenses clause than outright purchase is. The reasoning is that rental is an expense directly tied to recovery from the covered hospitalisation, not a standalone equipment acquisition. Insurers that reject a purchase claim have, on appeal, accepted a rental claim for the same recovery period.

The conversion logic therefore matters: if a family has paid the full purchase price and a rejection is likely, reframing the claim as “rental equivalent for the 60-day post-hospitalisation window” sometimes survives appeal even when the full purchase claim does not. This requires the dealer to issue a rental receipt alongside the sale invoice — an accommodation some dealers will make if asked at the time of purchase.

For purchases under rent-to-own structures, the monthly rental component paid during the hospitalisation follow-up window is usually eligible under post-hospitalisation; the conversion-to-own payment is not.

CGHS and ESIC do not have this distinction — they reimburse under their own rate card regardless of rent versus buy.

Coverage by scheme, at a glance

Scheme / insurer	Home oxygen covered?	Route	Typical ceiling
CGHS	Yes, for eligible beneficiaries	Empanelled vendor or reimbursement	Fixed per rate list
ESIC	Yes, for insured persons	Empanelled vendor only	Fixed per ESIC rates
PMJAY	State-dependent; not standard	State agency	Package-dependent
Star Health (standard indemnity)	No (DME excluded)	N/A	N/A
Star Senior Citizens Red Carpet	Partially, via rider	Reimbursement	Policy sub-limit
HDFC Ergo Optima (select riders)	Yes, with home healthcare add-on	Reimbursement	Sub-limit ₹25k–₹1L
ICICI Lombard Complete Health	Yes, with select variants	Reimbursement	Sub-limit
Tata AIG MediCare	Generally no; specific riders only	Reimbursement	Sub-limit
Bajaj Allianz Health Care Supreme	Generally no; rider-specific	Reimbursement	Sub-limit
Corporate group policy	Depends on employer-negotiated rider	Reimbursement (often cashless)	Employer-specific

This table is directional and policy-year-specific. Every family should verify by reading the policy wording and calling the TPA helpline before purchase.

The CAG view

The Comptroller and Auditor General of India (CAG) has repeatedly flagged gaps in healthcare scheme reimbursement, including slow DME reimbursement processing under CGHS and ESIC. The CAG audits of public health scheme performance have noted delays of 90+ days on DME reimbursement claims in multiple audit cycles, with administrative bottlenecks at the empanelled-vendor verification stage. (CGHS)

For families, the practical implication is: assume the reimbursement timeline is longer than the policy document says, maintain the full documentation set for the appeal that may follow, and treat the first claim submission as Round 1 of a process, not the end of it.

Practical takeaway

If the patient is a CGHS or ESIC beneficiary, use the empanelled vendor channel and plan for a reimbursement rate below sticker price. If the patient is on a private indemnity policy, read the DME clause before assuming coverage; most policies exclude it. For private policies that include a home healthcare rider, pre-authorise before purchase, collect the full documentation set (prescription with ABG, itemised invoice with GST breakup, warranty card), and use the reimbursement workflow — cashless will rarely be available because DME dealers are not empanelled with private TPAs. If the claim is rejected, request the rejection letter in writing with the clause cited, file an internal appeal within 30 days, and escalate to the Insurance Ombudsman if unresolved. Where purchase claims fail, reframing the first 60 days as rental sometimes survives appeal under the post-hospitalisation expenses clause. Consult your policy wording — not the brochure — before you buy.